Table 5.
Gene expression profiles of hepatic fibrogenesis in HFD and MCD diet-fed animal models.
Gene Symbol | Nomenclature | Role | Diet Type | Duration (Weeks) |
Animal Model | Gene Expression | Reference |
---|---|---|---|---|---|---|---|
ACTA2 (ASMA) |
Anti-smooth muscle actin | Activation to myofibroblast-like cell | HFD | 25 | C57BL/6 mice | Up | [22] |
COL1A1 | Collagen type 1 alpha 1 | Fibrillar forming collagen | HFD | 25 | C57BL/6 mice | Up | [22] |
24 | Male C57BL/6J mice | Up | [45] | ||||
MCD | 2 | Male SD rats | Up | [51] | |||
17 | Male SD rats | Up | [52] | ||||
COL1A2 | Collagen type I alpha 2 | HFD | 24 | Male C57BL/6J mice | Up | [45] | |
COL4A1 | Collagen type IV alpha 1 | HFD | 24 | Male C57BL/6J mice | Up | [45] | |
HGF | Hepatocyte growth factor | Hepatotropic factor, which acts as a growth factor | HFD | 25 | C57BL/6 mice | Up | [22] |
LUM | Lumican | Extracellular matrix structural constituent | HFD | 25 | C57BL/6 mice | Up | [22] |
MMP-13 | Matrix metalloproteinase-13 | Degradation of extracellular matrix proteins | MCD | 2 | Male SD rats | Up | [51] |
MMP-9 | Matrix metalloproteinase-9 | MCD | 2 | Male SD rats | Up | [51] | |
PAI-1 | Plasminogen activator inhibitor 1 | Inhibitor of tissue-type plasminogen activator (PLAT) and urokinase-type plasminogen activator (PLAU) | HFD | 24 | Male C57BL/6J mice | Up | [45] |
SOCS1 | Suppressor of cytokine signaling 1 | Prevents uncontrolled cytokine signaling | MCD | 2 | Male SD rats | Up | [51] |
TIMP-1 | Tissue inhibitor matrix metalloproteinase 1 (TIMP Metallopeptidase Inhibitor 1) | Inhibitor of collagenases by forming one to one complexes | MCD | 17 | Male SD rats | Up | [52] |
HFD | 25 | C57BL/6 mice | Up | [22] | |||
TGF-β1 | Transforming growth factor-beta 1 | Acts as a regulator of extracellular matrix storage | HFD | 25 | C57BL/6 mice | Up | [22] |
24 | Male C57BL/6J mice | Up | [45] |